AVEO Pharmaceuticals CEO Michael Bailey's 2020 pay rises 1% to $1.6M

AVEO Pharmaceuticals reports 2020 executive compensation

By ExecPay News

Published: April 28, 2021

AVEO Pharmaceuticals reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at AVEO Pharmaceuticals received on average a compensation package of $925K, a 9% decrease compared to previous year.
Average pay of disclosed executives at AVEO Pharmaceuticals
Michael Bailey, Chief Executive Officer, received $1.6M in total, which increased by 1% compared to 2019. 35% of Bailey's compensation, or $565K, was in salary. Bailey also received $441K in non-equity incentive plan, $524K in option awards, as well as $70K in other compensation.
For fiscal year 2020, the median employee pay was $338,785 at AVEO Pharmaceuticals. Therefore, the ratio of Michael Bailey's pay to the median employee pay was 5 to one.
Michael Needle, Chief Medical Officer, received a compensation package of $830K, which increased by 15% compared to previous year. 54% of the compensation package, or $452K, was in salary.
Erick Lucera, Chief Financial Officer, earned $781K in 2020.
Karuna Rubin, General Counsel, received $709K in 2020, which decreases by 5% compared to 2019.
Michael Ferraresso, Chief Commercial Officer, earned $707K in 2020.

Related executives

Michael Bailey

AVEO Pharmaceuticals

Chief Executive Officer

Michael Needle

AVEO Pharmaceuticals

Chief Medical Officer

Karuna Rubin

AVEO Pharmaceuticals

General Counsel

Erick Lucera

AVEO Pharmaceuticals

Chief Financial Officer

Michael Ferraresso

AVEO Pharmaceuticals

Chief Commercial Officer

You may also like

Source: SEC filing on April 28, 2021.